Term
What is a Paraneoplastic Syndrome? |
|
Definition
A neoplasm-associated alteration in bodily structure or function that occurs distant to the tumor. |
|
|
Term
What causes a Paraneoplastic Syndrome? |
|
Definition
Cancer Cells releasing hormones, hormone-like substances, or polypeptides tha act on Target Tissues in the local area or are released in circulation to act on organ sites DISTANT from the tumor.
***PNS may the the first clinical Manifestation of a tumor*** |
|
|
Term
T/F
PNS can cause greater morbidity than the cancer itself? |
|
Definition
|
|
Term
What are the LOCAL COMPLICATIONS of cancer? |
|
Definition
- Infiltration and destruction of normal tissue
- Obstruction of Hollow organs
- Circulatory Disturbances
- Local bleeding (hemopthysis, melena, hematuria)
|
|
|
Term
|
Definition
Weight Loss and metabolic alterations that occur DESPITE ADEQUATE nutritional intake
*Incidence in veterinary cancer patients esteimated to be <25%* |
|
|
Term
|
Definition
Alterations due to poor nutritional intake. |
|
|
Term
What can Cancer Cachexia-Anorexia (CACS) be attributed to? |
|
Definition
- Some instances can be attributed directly to the growth or spread of the neoplasm or to therapy
- Others, cachexia results from production of cytokines (IL-1, IL-6, TNF, IF-γ)by host tissues in response to cancer
|
|
|
Term
What are the abnormalities in substrate metabolism associated with Cancer Cachexia-Anorexia (CACS)? |
|
Definition
- Insulin Resistance
- Glucose Intolerance
- Increased Gluconeogenesis
- Increased Cori cycle activity
- Increased Fatty acid metabolism
- Hyperlipidemia
- Increased Protein turnover
- Increased skeletal muscle catabolism
|
|
|
Term
What are the thereputic considerations when treating cancer Cachexia? |
|
Definition
- Treatment of the underlying tumor(best approach)
- Total Parenteral Nutrition
***objective is to enhance immune-system function, response to, and tolerance of cancer therapy*** |
|
|
Term
T/F:
The way to detect a Protein-Losing Enteropathy in the veterinary cancer patient is to detect α-1-Antitripsin in stools. |
|
Definition
FALSE
*detection of the alpha-1-antitripsin in stools is the way to detect a PLE in humans but hasn't been extensively evaluated in veterinary medicine*** |
|
|
Term
What is the most common cause of PNS-associated Gastroduodenal ulceration? |
|
Definition
Mast Cell Tumor (degranulation of mast cell->excess release of histamine->bind to H2 receptors->Increase gastric acid production->mucosal damage or ulceration)
***Gastrinomas are also associated with PNS-GI ulceration*** |
|
|
Term
T/F:
Lymphoma is the most common cause of HM (Hypercalcemia of Malignancy). |
|
Definition
TRUE
***most common cause of hypercalcemia in dogs and cats is cancer (2/3 dogs, 1/3 cats)*** |
|
|
Term
What is the pathogenesis of Hypercalcemia of Malignancy? |
|
Definition
Multifactorial:
- Release of osteoclast-activating factor (multiple myeloma)
- Bone destruction by neoplastic cells (bone tumors)
- Secretion of humoral factor (PTH, PTHrp) by neoplastic cells (lymphoma, Anal Sac Apocrine Gland Adenocarcinomas)
|
|
|
Term
How is Hypercalcemia of Malignancy diagnosed? |
|
Definition
- R/O Lipemia and Hemolysis
- Interpret the total calcium in relation to the level of serum albumin (Adjusted Calcium (mg/dl)=[calcium (mg/d)-albumin (g/dl)]+3.5)
***an increase in free ionized calcium can occur in acidotic HM patients*** |
|
|
Term
T/F:
Renal function impairment is insignificant in Hypercalcemia of Malignancy and if present is usually the last sign exhibited |
|
Definition
FALSE
***Renal Function impairment is the first manifestation of HM*** |
|
|
Term
What are therapy indications for Hypercalemia of Malignancy? |
|
Definition
- Mild hypercaclemia, minimal clinical signs: Rehydrate patient and correct underlying neoplasm
- Moderate Hypercalcemia and clinical signs: Rehydrate as above, furosemide, glucocorticoids
- Severe Hypercalcemia and clinical signs: As above plus consider bisphosphates and calcitonin for refractory cases
***If a diagnosis of lymphoma is being considered, glucocorticoids should be delayed until a definitive diagnois has been established since these drugs may alter lymph node morphology!*** |
|
|
Term
T/F:
Insulinoma is the most common cause of hypoglycemia in dogs and the neoplasm most associated with hypoglycemia in cats. |
|
Definition
|
|
Term
What is the pathogenesis of PNS-Hypocalcemia? |
|
Definition
Islet Cell Tumors
- excessive insulin produced be the tumor
Non-islet cell tumors:
- Ectopic Insulin production
- Production of a substance with insulin-like activity *most likely*
- Over-utilization of glucose by the tumor
- Inhibition of hepatic glucose output
|
|
|